Clinical trial
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
NCT00146536 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00146536 |
|---|---|
| Title | Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy |
| Official title | The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS, or Atypical Ductal Hyperplasia (ADH) in Patients Diagnosed With Lobular Neoplasia of the Breast by Core Needle Biopsy |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Translational Breast Cancer Research Consortium Beth Israel Deaconess Medical Center Brigham and Women's Hospital |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Neoplasms |
| Enrollment | 78 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Sep 7, 2005 |
| Last update posted | Mar 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: